Timber Creek Capital Management LLC Abbott Laboratories Transaction History

Timber Creek Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$95.06 - $111.52 $6,178 - $7,248	-65 Closed	0 $0
Q3 2021 Oct 08, 2021	SELL	$116.66 - $129.06 $5,833 - $6,453	-50 Reduced 43.48%	65 $7,000
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $13,605 - $16,028	-125 Reduced 52.08%	115 $13,000
Q2 2020 Jul 31, 2020	SELL	$76.57 - $98.0 $19,908 - $25,480	-260 Reduced 52.0%	240 $21,000
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $6,622 - $8,006	-100 Reduced 16.67%	500 $39,000

Q4 2018 Jan 30, 2019	BUY	$65.56 - $74.27 $7,211 - $8,169	110 Added 22.45%	600 $43,000
Q1 2018 Apr 30, 2018	SELL	$56.27 - $63.62 $1,969 - $2,226	-35 Reduced 6.67%	490 $29,000
Q2 2017 Aug 11, 2017	BUY	N/A	525	525 $23,000

3,130

1.29B

8.43M

8.71M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Timber Creek Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Timber Creek Capital Management LLC with notifications on news.